Published in J Bone Miner Res on December 01, 2003
18F-NaF PET in Detecting Metastatic Bone Lesion for Patients With Cancer. | NCT00414934
Can 16-detector multislice CT exclude skeletal lesions during tumour staging? Implications for the cancer patient. Eur Radiol (2006) 1.66
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy. Eur J Nucl Med Mol Imaging (2011) 1.63
The isotope bone scan: we can do better. Eur J Nucl Med Mol Imaging (2013) 1.39
The EANM practice guidelines for bone scintigraphy. Eur J Nucl Med Mol Imaging (2016) 1.04
The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med (2012) 0.98
PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery. Skeletal Radiol (2006) 0.98
Usefulness of (18)F-fluoride PET/CT in Breast Cancer Patients with Osteosclerotic Bone Metastases. Nucl Med Mol Imaging (2012) 0.90
PET and PET/CT imaging of skeletal metastases. Cancer Imaging (2010) 0.88
Therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain. Skeletal Radiol (2010) 0.86
Targeted treatments of bone metastases in patients with lung cancer. Front Oncol (2014) 0.85
Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases. Theranostics (2015) 0.84
Cost-effectiveness of Fluorine-18-Fluorodeoxyglucose positron emission tomography in tumours other than lung cancer: A systematic review. World J Radiol (2014) 0.82
Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis. Korean J Radiol (2013) 0.79
Management of skeletal metastases: An orthopaedic surgeon's guide. Indian J Orthop (2015) 0.78
Comparison of standardized uptake values measured on F-NaF PET/CT scans using three different tube current intensities. Radiol Bras (2015) 0.78
Receiver operating characteristic (ROC) curve for classification of (18)F-NaF uptake on PET/CT. Radiol Bras (2016) 0.78
Added value of using a cocktail of F-18 sodium fluoride and F-18 fluorodeoxyglucose in positron emission tomography/computed tomography for detecting bony metastasis: a case report. Medicine (Baltimore) (2015) 0.77
(18)F-NaF PET/CT: EANM procedure guidelines for bone imaging. Eur J Nucl Med Mol Imaging (2015) 0.76
When to perform positron emission tomography/computed tomography or radionuclide bone scan in patients with recently diagnosed prostate cancer. Cancer Manag Res (2013) 0.76
Enhancement of the Regenerative Potential of Anorganic Bovine Bone Graft Utilizing a Polyglutamate-Modified BMP2 Peptide with Improved Binding to Calcium-Containing Materials. Tissue Eng Part A (2015) 0.76
Skeletal metastases: what is the future role for nuclear medicine? Eur J Nucl Med Mol Imaging (2009) 0.75
Imaging with non-FDG PET tracers: outlook for current clinical applications. Insights Imaging (2010) 0.75
Melorheostosis associated with peripheral form spondyloarthropathy: new image with 18-fluoride positron emission tomoscintigraphy coupled to computed tomography. Open Access Rheumatol (2012) 0.75
The role of 18F-NaF PET/CT in metastatic bone disease. J Bone Oncol (2015) 0.75
Complementary findings on (18)F-FDG PET/CT and (18)F-NaF PET/CT in a patient with Erdheim-Chester disease. Radiol Bras (2017) 0.75
T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol (2008) 5.44
Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology (2014) 3.22
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med (2003) 3.10
Review: health care utilization and costs of elderly persons with multiple chronic conditions. Med Care Res Rev (2011) 2.93
Prediction of institutionalization in the elderly. A systematic review. Age Ageing (2009) 2.77
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol (2009) 2.23
Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med (2005) 2.17
The influence of age, gender and socio-economic status on multimorbidity patterns in primary care. First results from the multicare cohort study. BMC Health Serv Res (2012) 2.11
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT. Eur J Nucl Med Mol Imaging (2010) 2.07
Cryoprobe biopsy increases the diagnostic yield in endobronchial tumor lesions. J Thorac Cardiovasc Surg (2010) 1.96
Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2009) 1.87
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging (2007) 1.84
Cost-of-illness studies of depression: a systematic review. J Affect Disord (2006) 1.81
Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty. Circulation (2003) 1.71
PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res (2002) 1.66
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature (2013) 1.66
Myocardial biopsy findings and gadolinium enhanced cardiovascular magnetic resonance in dilated cardiomyopathy. Eur J Heart Fail (2005) 1.57
Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration (2009) 1.56
Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? Eur J Cardiothorac Surg (2012) 1.53
Early retirement in cancer patients with or without comorbid mental health conditions: a prospective cohort study. Cancer (2014) 1.52
Prevalence of myocardial scar in patients with cryptogenic cerebral ischemic events and patent foramen ovale. JACC Cardiovasc Imaging (2010) 1.48
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging (2002) 1.48
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab (2012) 1.47
3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res (2002) 1.46
Molecular imaging of proliferation in malignant lymphoma. Cancer Res (2006) 1.46
Myocardial biopsy based classification and treatment in patients with dilated cardiomyopathy. Int J Cardiol (2005) 1.45
Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer. J Nucl Med (2010) 1.45
Prediction of institutionalisation in dementia. A systematic review. Dement Geriatr Cogn Disord (2008) 1.44
In vivo micro-CT imaging of untreated and irradiated orthotopic glioblastoma xenografts in mice: capabilities, limitations and a comparison with bioluminescence imaging. J Neurooncol (2015) 1.43
The German MultiCare-study: Patterns of multimorbidity in primary health care - protocol of a prospective cohort study. BMC Health Serv Res (2009) 1.43
Effects of psychiatric comorbidity on costs in patients undergoing disc surgery: a cross-sectional study. Spine J (2011) 1.42
Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients. Circulation (2005) 1.42
Impact of percutaneous device implantation for closure of patent foramen ovale on valve insufficiencies. Circulation (2009) 1.41
Results of intracoronary stem cell therapy after acute myocardial infarction. Am J Cardiol (2010) 1.40
Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int (2002) 1.39
Endobronchial tumor debulking with a flexible cryoprobe for immediate treatment of malignant stenosis. J Thorac Cardiovasc Surg (2009) 1.38
Early response assessment using 3'-deoxy-3'-[18F]fluorothymidine-positron emission tomography in high-grade non-Hodgkin's lymphoma. Clin Cancer Res (2007) 1.38
Gene silencing by adenovirus-delivered siRNA. FEBS Lett (2003) 1.37
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study. Clin Cancer Res (2008) 1.37
Imaging prostate cancer with 11C-choline PET/CT. J Nucl Med (2006) 1.33
Epidemiology of falls in residential aged care: analysis of more than 70,000 falls from residents of bavarian nursing homes. J Am Med Dir Assoc (2011) 1.31
Breaking chemoresistance and radioresistance with [213Bi]anti-CD45 antibodies in leukemia cells. Cancer Res (2007) 1.29
Reliability of symptoms to determine use of bone scans to identify bone metastases in lung cancer: prospective study. BMJ (2004) 1.28
C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol (2004) 1.27
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience. Radiology (2006) 1.25
Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler Thromb Vasc Biol (2003) 1.22
Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis. J Nucl Med (2007) 1.20
The role of monetary and nonmonetary incentives on the choice of practice establishment: a stated preference study of young physicians in Germany. Health Serv Res (2009) 1.20
Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm (2003) 1.20
Costs of inflammatory bowel disease in Germany. Pharmacoeconomics (2006) 1.19
Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation (2003) 1.19
Risk of dementia in elderly patients with the use of proton pump inhibitors. Eur Arch Psychiatry Clin Neurosci (2014) 1.18
[(68)Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction. JACC Cardiovasc Imaging (2015) 1.17
C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes (2004) 1.17
Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population. Eur Heart J (2008) 1.16
Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom (2012) 1.16
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry. Eur J Nucl Med Mol Imaging (2010) 1.14
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. EJNMMI Res (2012) 1.14
The stigma of obesity in the general public and its implications for public health - a systematic review. BMC Public Health (2011) 1.13
Economic costs of overweight and obesity. Best Pract Res Clin Endocrinol Metab (2013) 1.13
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries. Value Health (2011) 1.10
Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT. Eur J Nucl Med Mol Imaging (2007) 1.10
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. FASEB J (2004) 1.10
[The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population]. Psychother Psychosom Med Psychol (2006) 1.10
The impact of ageing on hospital care and long-term care--the example of Germany. Health Policy (2004) 1.09
Relative impact of multimorbid chronic conditions on health-related quality of life--results from the MultiCare Cohort Study. PLoS One (2013) 1.09
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine. J Nucl Med (2008) 1.08
C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res (2006) 1.08
mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression. J Cell Mol Med (2007) 1.08
Mild cognitive impairment: incidence and risk factors: results of the leipzig longitudinal study of the aged. J Am Geriatr Soc (2010) 1.07
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial. Arterioscler Thromb Vasc Biol (2006) 1.07
Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction. J Cardiovasc Magn Reson (2006) 1.05
Obese children, adults and senior citizens in the eyes of the general public: results of a representative study on stigma and causation of obesity. PLoS One (2012) 1.05
LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler Thromb Vasc Biol (2006) 1.04
Service utilization and health-care costs in the advanced elderly. Value Health (2007) 1.04
[(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy. World J Urol (2009) 1.04
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma. Eur J Nucl Med Mol Imaging (2007) 1.03
Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Invest Radiol (2013) 1.02
Does GP training in depression care affect patient outcome? - A systematic review and meta-analysis. BMC Health Serv Res (2012) 1.02
Biological characterisation of breast cancer by means of PET. Eur J Nucl Med Mol Imaging (2004) 1.02
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry. J Cardiovasc Magn Reson (2009) 1.02
The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning. Drug Alcohol Depend (2006) 1.01
Predictors of nursing home admission of individuals without a dementia diagnosis before admission - results from the Leipzig Longitudinal Study of the Aged (LEILA 75+). BMC Health Serv Res (2010) 1.01
Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing. Trop Med Int Health (2008) 1.01
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer. Radiother Oncol (2011) 1.01
Predictive value of initial 18F-FLT uptake in patients with aggressive non-Hodgkin lymphoma receiving R-CHOP treatment. J Nucl Med (2011) 1.01
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes (2004) 1.01
Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis (2010) 0.99
Combined assessment of myocardial perfusion and late gadolinium enhancement in patients after percutaneous coronary intervention or bypass grafts: a multicenter study of an integrated cardiovascular magnetic resonance protocol. JACC Cardiovasc Imaging (2009) 0.99
Rationale and content of psychenet: the Hamburg Network for Mental Health. Eur Arch Psychiatry Clin Neurosci (2012) 0.99
Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. J Affect Disord (2008) 0.99